DN
David Nierengarten
#694 out of 1699 analysts
Wedbush
Automatically Tracked
Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
Gain and growth charts are calculated per selected timeframe:
1.43%
Gain +2.72%
Monthly
0.03%
Yearly
0.36%
Drawdown
11.7%
$142,541.62
Equity
Holdings
$104,110.82
Cash
$38,430.8
Investment
$99,154.6
$4,711.47
Profit +$3,768.09
Realized
-$244.75
Unrealized
$4,956.21
Dividends
$0
$38,430.8
Cash
Deposits
$137,830.15
Withdrawals
$0
Commissions
$0
Goals
Avg. 0% completed goals
Today
Compared To Yesterday
Gain
2.72%
Profit
$3,768.09
Win %
90%
This Week
Compared To Last Week
Gain
2.97%
Profit
$4,113.84
Win %
90%
This Month
Compared to last month
Gain
-2.6%
Profit
-$3,803.97
Win %
77%
This Year
Compared to last year
Gain
-1.14%
Profit
-$1,636.89
Win %
71%
COAG Hemab Therapeutics Holdings, Inc.
+8.2%
+$389.87 
NUVB Nuvation Bio Inc.
+3.96%
+$199.17 
STTK Shattuck Labs Inc.
+2.95%
+$138.94 
STRO Sutro Biopharma, Inc.
+2.59%
+$128.05 
BCAX Bicara Therapeutics Inc.
+2.13%
+$110.91 
DMRA Damora Therapeutics, Inc.
+1.9%
+$87.84 
COGT Cogent Biosciences, Inc.
+1.84%
+$90.85 
APGE Apogee Therapeutics Inc.
+1.83%
+$84.72 
KNSA Kiniksa Pharmaceuticals International, plc
+1.83%
+$92.94 
BOLD Boundless Bio, Inc.
+1.79%
+$80.03 
FENC Fennec Pharmaceuticals Inc.
+1%
+$47.02 
TLX Telix Pharmaceuticals Limited American Depositary Receipt
+0.91%
+$43.99 
ORIC Oric Pharmaceuticals Inc.
+0.32%
+$16.61 
NUVL Nuvalent, Inc.
+0.04%
+$2.75 
ABVX Abivax SA ADR
-1.57%
+$70.51 
ARGX argenx SE American Depositary Receipt
-1.12%
-$50.95 
IMNM Immunome Inc.
-0.69%
-$31.07 
IRON Disc Medicine Inc.
-0.54%
-$25.79 
ODTX Odyssey Therapeutics, Inc.
-0.38%
-$19.37 
SYRE Spyre Therapeutics, Inc.
-0.34%
-$18.52 
SRRK Scholar Rock Holding Corporation
-0.31%
-$15.06 Events
Loading...
Dividends
Dividend Analysis
Loading...
No Data
| Trades 163 | Longs Won 96/156 61% | Profit Factor 1.15 |
| Profitability | Shorts Won 3/7 42% | Standard Deviation $728.51 |
| Average Win $374.28 | Best Trade (Dec 11) $2,661.2 | Sharpe Ratio -726.47 |
| Average Loss -$505.35 | Worst Trade (Jun 02) -$4,518.65 | Z-Score 1.77 (92.37%) |
| Commissions $0 | Avg. Trade Length 2m 1w 3d | Expectancy $28.9 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.04% | 0.4% | 3.15% | 19.53% |
| Consecutive Losing Trades | 282 | 254 | 226 | 197 | 169 | 141 | 113 | 85 | 56 | 28 |
Hover over the desired column for a detailed explanation.
Returns
Overall, MonthlyNo Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
